White paperThe Enterprise Framework for Compliant, Scalable AI
Download now

Regulatory Requirements

Regulatory Requirements for Life Sciences

Regulatory expectations are converging across FDA, EMA, MHRA, and ICH. USDM helps life sciences teams translate 21 CFR Part 11, CSA, Annex 11, UDI/EU MDR, data integrity, privacy/security, and AI oversight into a controlled operating model that is inspection-ready, scalable, and defensible.

Contact USDM Explore details

21 CFR Part 11 Compliance

21 CFR Part 11 Compliance for Modern Life Sciences Operations

21 CFR Part 11 compliance helps life sciences organizations maintain secure electronic records, validated systems, and trustworthy electronic signatures. USDM supports compliance with audit-ready processes, stronger access controls, automation, and continuous oversight, helping teams reduce risk, improve inspection readiness, and build quality operations that scale with modern digital and AI-enabled environments.

Read the Blog

Computer System Validation Services, CSV vs CSA

Computer System Validation Services for Modern Compliance

Computer System Validation Services help life sciences companies modernize compliance while reducing cost and complexity. USDM provides both traditional validation and the transition from CSV to CSA through scalable, risk-based approaches, automation, and cloud-ready compliance services. The result is stronger quality, faster implementation, and a more efficient validation strategy built for regulated digital environments.

Read the Blog

Computer Software Assurance (CSA)

Computer Software Assurance (CSA) for Modern Validation

Computer Software Assurance (CSA) helps life sciences organizations modernize validation with a more risk-based, efficient approach than traditional CSV. With deep experience in FDA expectations, automated testing, and regulated system compliance, USDM enables teams to apply CSA in practical ways that improve quality, accelerate delivery, and build more scalable validation strategies. The result is a stronger compliance model designed for modern regulated environments.

Download the White Paper

UDI/EU MDR

UDI/EU MDR Readiness for EUDAMED Compliance

UDI and EU MDR requirements are accelerating as EUDAMED modules go live, raising the stakes for medical device and IVD manufacturers. USDM strengthens readiness through digital compliance strategies, content harmonization, and trusted regulatory support that help teams navigate deadlines, reduce risk, and improve execution. The result is a stronger, more structured path to EU MDR and IVDR compliance in an increasingly demanding regulatory environment.

Download our Medical Device Manufacturer Datasheet Read the blog

AI and connected workflows

AI Governance Now Belongs in the Regulatory Stack

AI guidance is moving from theory to operating expectation. Whether the use case is drafting, decision support, or embedded product capability, leaders need intended use, human oversight, change control, vendor visibility, and traceable evidence.

AI governance and compliance Audit-readiness

What USDM does

Regulatory Modernization Should Support the Business

USDM connects requirements mapping, control design, validation strategy, evidence architecture, and stakeholder alignment so compliance strengthens speed instead of slowing it down. The result is a pathway that lets the organization move without guessing at the regulatory edge cases.

Explore regulatory requirements Talk to USDM

Deep dives

Go deeper on the topics that matter most.

Explore detailed briefs on high-priority regulatory, compliance, and AI topics — each connecting USDM expertise to the specific challenges your organization faces.

21 CFR Part 11 Compliance: A Practical Guide for Life Sciences Companies

Learn how to achieve 21 CFR Part 11 compliance with secure electronic records, audit trails, eSignatures, and validation best practices for life sciences.

Read now

Computer Software Assurance (CSA): What Life Sciences Companies Need to Know

Learn what Computer Software Assurance (CSA) means for life sciences, how it differs from traditional validation, and how to apply a risk-based FDA-aligned approach.

Read now

Computer System Validation Services: Rethinking CSV vs CSA for Life Sciences Innovation

Explore computer system validation services, understand CSV vs CSA, and learn how life sciences companies can modernize validation to improve compliance, speed, and scalability.

Read now

EU MDR/IVDR EUDAMED Readiness What Medical Device Manufacturers Need to Do Now

Learn how to improve EU MDR/IVDR EUDAMED readiness with practical steps for data, registration, governance, and global medical device regulatory alignment.

Read now

Frequently Asked Questions

Questions leaders ask before they move.

Why do converging regulatory frameworks require a transformation response instead of a traditional compliance response?

Converging frameworks affect overlapping systems, data structures, validation methods, quality processes, and governance models. Updating SOPs alone is not enough; organizations need a coordinated strategy that redesigns processes, platforms, controls, and operating models together.

What makes the current regulatory environment different for life sciences companies?

Several major frameworks are converging at the same time: ICH E6(R3), FDA direction around AI and lifecycle oversight, EU AI Act expectations, CSA, 21 CFR Part 11, and UDI/EU MDR. Together, they demand connected transformation rather than fragmented remediation.

How does Computer Software Assurance (CSA) change validation strategy?

CSA shifts validation from documentation volume toward evidence of system performance, intended use, critical thinking, and quality outcomes. It makes validation more efficient, scalable, and aligned with fast-moving technology environments.

What role does 21 CFR Part 11 compliance play in digital transformation?

Part 11 remains foundational because regulated digital transformation depends on trustworthy electronic records, secure electronic signatures, controlled access, and complete audit trails. It becomes part of the transformation architecture, not a legacy checklist.

Why do UDI/EU MDR and EU AI requirements need to be addressed together?

Both affect regulated data, system controls, traceability, and oversight. Since they touch shared processes and platforms, organizations should address medical device regulatory readiness and AI governance through one coordinated operating model.

How can life sciences companies respond effectively to converging regulatory frameworks?

They need a unified operating model that connects Part 11, CSV/CSA, AI governance, and UDI/EU MDR readiness with regulatory expertise, GxP validation depth, platform understanding, and operating model design.

How can life sciences companies improve compliance across 21 CFR Part 11, CSV, CSA, and UDI/EU MDR?

The strongest approach combines validated systems, risk-based assurance, automation, traceability, and regulatory readiness so organizations can reduce gaps, improve inspection readiness, and support scalable digital transformation.

What is Computer Software Assurance (CSA)?

CSA is the FDA’s risk-based framework for assuring that software used in production and quality systems performs as intended. It shifts attention from heavy documentation to critical thinking, intended use, and the level of assurance that matches patient safety, product quality, and process risk.

How does CSV vs CSA change the validation conversation?

CSV emphasizes documented evidence that a system performs as intended in a compliant state, while CSA emphasizes risk-based assurance, unscripted testing where appropriate, and more efficient evidence for lower-risk functions. The goal is smarter validation, not lighter validation.

What are computer system validation services?

Computer system validation services help regulated organizations ensure systems consistently perform as intended, protect data integrity, and meet applicable compliance requirements. They typically include validation planning, risk assessment, traceability, testing, documentation, change control support, vendor oversight, and ongoing compliance monitoring.

What do teams need to know about UDI/EU MDR readiness?

Teams should confirm they have a validated and governed source of truth for UDI-related product data, can distinguish which devices must be registered now versus later, understand how device or label changes affect obligations, and have tools and teams that can support ongoing maintenance after the initial submission wave.

Talk to a regulatory specialist

Get compliant — and build the evidence to prove it.

USDM consultants work inside GxP environments every day. We help regulated organizations satisfy FDA, EMA, and global regulatory requirements without proportional increases in headcount.

  • 21 CFR Part 11, CSV/CSA, and UDI/EU MDR expertise
  • Defensible validation evidence and documentation
  • Computer Software Assurance (CSA) strategy
  • Inspection-ready systems and processes

Talk to a specialist

Speak with a regulatory expert

Tell us what regulatory pressure you're navigating and we'll map a defensible path through Part 11, CSA/CSV, Annex 11, data integrity, privacy/security, and AI oversight.

By submitting this form, you agree to USDM’s Privacy Policy and consent to receive communications from USDM. You can unsubscribe at any time using the link in our emails.